Havrix 720 (Junior)

• Active immunisation against Hepatitis A virus

The hepatitis A virus belongs to the picornavirus family. It is one of several hepatitis viruses that cause systemic disease with pathology in the liver. The incubation period for hepatitis A averages 28 days (range: 15 to 50 days). The course of hepatitis A infection is extremely variable, ranging from asymptomatic infection to icteric hepatitis and death. The presence of antibodies to HAV confers protection against hepatitis A infection.

Adult Dose (IM):

• 2-dose vaccination series: 1 mL IM
• Separate the 2 doses by 6-12 months

Child Dose (IM):

• 12-23 months: 0.5 mL IM
• 2 doses separated by 6-12 months
• If child received 1 dose before 24 months, second dose should be given 6-12 months later

* Use as directed by the registered physician

Common Side Effects (>10%):

• Injection site tenderness (3-56%)
• Erythema (1-22%)
• Warmth (1-17%)
• Swelling (9-11%)
• Irritability (11-36%)
• Anorexia (1-19%)
• Drowsiness (15-17%)
• Headache (1-16%)
• Fever > 100.4°F (9-11%)

1-10%: URI, Otitis media, Rhinorrhea, Diarrhea, Cough, Rash, Weakness/fatigue, Vomiting

Potentially Fatal: Anaphylaxis

Use in Pregnancy: Vaccine should be given to pregnant women only if clearly needed.

Precautions:

• Alcohol or disinfectant used for cleaning the skin should be allowed to evaporate completely before vaccination (to prevent vaccine inactivation)
• Vaccine should be given to pregnant women only if clearly needed
• Remain under medical supervision for 30 minutes after vaccination
• Adrenaline and other first aid medicines should be prepared

Overdose: Limited information available on overdose. Employ usual supportive measures.

Storage: Store and transport at 2°C-8°C. Do not freeze. Protect from light.